David Steensma

33PUBLICATIONS
132CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematologyEcohydrologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 09, 2025
Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies.

Bita Bashy, Darshi Shah, David Steensma

|Dec 09, 2024
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis.

Tamanna Haque, Aditi Shastri, Pinkal Desai

|Nov 15, 2024
Clonal haemopoiesis and venous thromboembolism risk.

David P Steensma

|May 03, 2024
Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial.

Janghee Woo, Tingting Zhai, Fang Yang

|Feb 08, 2024
Altered Oxidative Phosphorylation Confers Vulnerability on IDH1-Mutant Leukemia Cells: Is This Therapeutically Tractable?

David P Steensma

|Dec 03, 2023
Revisiting the first reported case of aplastic anaemia.

David P Steensma

Pageof 6

Frequent Collaborators

4 joint publications

Rami S Komrokji

4 joint publications

Benjamin L Ebert

3 joint publications

Uwe Platzbecker

3 joint publications

Gail Roboz